Drug interactions and metabolism Weight loss associated with GLP-1R use may alter drug metabolism of weight-based medications (e.g., levothyroxine, warfarin )
Long-term considerations Because these drugs are so new, there are a lot of long-term considerations we dont have solid answers for yet
Recent multi-omics analyses by Cappellani et al., for instance, have provided strong genetic and proteomic evidence linking DR pathogenesis directly to the activation of specific immune pathways, including the complement system and adaptive T-cell responses [53, 58, 59]
Low Blood Sugar While Ozempic probably does not itself cause low blood sugar (hypoglycemia), its glucose-lowering effect can sharply increase the odds that other drugs, principally insulin or sulfonylureas, cause hypoglycemia
Patients were also required to have at least one outpatient encounter within the four years prior the prescription
Close observation helps manage adverse reactions swiftly and ensures the treatment remains effective